Literature DB >> 3678001

The effect of fluphenazine on rod-mediated retinal responses.

T Schneider1, E Zrenner.   

Abstract

The effect of various concentrations of the dopamine antagonist fluphenazine on ocular field potentials, recorded under scotopic conditions from isolated, arterially perfused cat eyes, was studied. Responses from outer (isolated PIII-component of the electroretinogram, ERG), middle (b-wave), and inner (optic nerve response, ONR) retinal layers were separated. Neither the fast or slow PIII-amplitude nor the temporal characteristics of the response were influenced by any of the drug concentrations tested. In contrast, fluphenazine reversibly increased the rod b-wave amplitude over a large range of concentrations. Only very high drug concentrations led to an irreversible loss of the b-wave. In the ONR the initial transient on-response increased during drug injection, whereas the sustained on-response and off-response decreased. In summary, the dopamine antagonist fluphenazine affects mainly the signal processing of the rod pathway in the inner retinal layers, while responses from outer retinal layers are not influenced. On- and off-responses of the ONR are affected differently.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3678001     DOI: 10.1007/bf00149935

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  19 in total

1.  Retinal function in an isolated, perfused mammalian eye.

Authors:  P Gouras; M Hoff
Journal:  Invest Ophthalmol       Date:  1970-05

2.  Morphology of catecholamine-containing amacrine cells in the cat's retina, as seen in retinal whole mounts.

Authors:  I Törk; J Stone
Journal:  Brain Res       Date:  1979-06-22       Impact factor: 3.252

3.  Signal transmission along retinal rods and the origin of the electroretinographic a-wave.

Authors:  R D Penn; W A Hagins
Journal:  Nature       Date:  1969-07-12       Impact factor: 49.962

4.  The inhibition of retinal ganglion cells by catecholeamines and gamma-aminobutyric acid.

Authors:  M Straschill; J Perwein
Journal:  Pflugers Arch       Date:  1969       Impact factor: 3.657

5.  Towards an understanding of the role of dopamine in the mammalian retina.

Authors:  R J Jensen; N W Daw
Journal:  Vision Res       Date:  1983       Impact factor: 1.886

6.  Dopaminergic amacrine cells in the cat retina.

Authors:  R G Pourcho
Journal:  Brain Res       Date:  1982-12-02       Impact factor: 3.252

7.  Blue-sensitive cones of the cat produce a rodlike electroretinogram.

Authors:  E Zrenner; P Gouras
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-10       Impact factor: 4.799

Review 8.  Electrical activity of vertebrate photoreceptors.

Authors:  T Tomita
Journal:  Q Rev Biophys       Date:  1970-05       Impact factor: 5.318

9.  Action of iontophoretically applied dopamine on cat retinal ganglion cells.

Authors:  P Thier; V Alder
Journal:  Brain Res       Date:  1984-01-30       Impact factor: 3.252

10.  Effects of haloperidol, methylergometrine and phentolamine on the frog ERG.

Authors:  P Kupenova; S Belcheva
Journal:  Experientia       Date:  1981
View more
  6 in total

1.  Dopamine and serotonin in cat retina: electroretinography and histology.

Authors:  W Skrandies; H Wässle
Journal:  Exp Brain Res       Date:  1988       Impact factor: 1.972

2.  Effect of levodopa on the human pattern electroretinogram and pattern visual evoked potentials.

Authors:  I Gottlob; H Weghaupt; C Vass; E Auff
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

3.  The effects of dopamine blockade on the human flash electroretinogram.

Authors:  K Holopigian; L Clewner; W Seiple; M J Kupersmith
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

4.  Selective effects of retinal dopamine depletion on partial ischemia-induced electroretinographic hyperresponses in rabbits.

Authors:  G Lafond; W Cao; A Drumheller; F B Jolicoeur; M Zaharia; J Realbrunette
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

Review 5.  In vitro techniques for the assessment of neurotoxicity.

Authors:  G J Harry; M Billingsley; A Bruinink; I L Campbell; W Classen; D C Dorman; C Galli; D Ray; R A Smith; H A Tilson
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

6.  Ophthalmologic Baseline Characteristics and 2-Year Ophthalmologic Safety Profile of Pramipexole IR Compared with Ropinirole IR in Patients with Early Parkinson's Disease.

Authors:  William Seiple; Danna Jennings; Richard B Rosen; Leona Borchert; Lee Canale; Nora Fagan; Mark Forrest Gordon
Journal:  Parkinsons Dis       Date:  2016-12-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.